A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
SARS-CoV-2 Nucleocapsid Assembly Inhibitors: Repurposing Antiviral and Antimicrobial Drugs Targeting Nucleocapsid-RNA Interaction
<p>SARS-CoV-2 pandemic has become a serious concern due to high transmission of this virus and unavailability of any definitive drugs yet in clinics. While novel antivirals are under investigation stage, scientists are also rigorously trying to use drug repurposing as an option to fight against this highly infectious novel coronavirus. Several drugs are under regular use for other diseases that are getting screened for their usability against SARS-CoV2. In this study we have targeted SARS-CoV-2doi:10.26434/chemrxiv.12587336 fatcat:e2ioy5a3qng23gdthk5iffocwm